Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MRSA Right-sided Endocarditis”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT00770341
What this trial is testing

MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Who this might be right for
Staphylococcal Infection
Merck Sharp & Dohme LLC 122
Not applicableNo Longer AvailableNCT04597242
What this trial is testing

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

Who this might be right for
MRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more
ContraFect
Testing effectiveness (Phase 2)Ended earlyNCT00695903
What this trial is testing

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Who this might be right for
Endocarditis, BacterialInfective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation